advanced search

INJECTION

Interview: Arnaud Guillet, Biocorp
INTERVIEW
Arnaud Guillet
Biocorp
Interview: Arnaud Guillet, Biocorp
In this exclusive interview with ONdrugDelivery, Arnaud Guillet discusses Mallya, Biocorp’s connected clip-on for pen injectors, including Mallya’s successful launch in multiple countries this year, the factors that have played into the device’s success, and the future for Mallya, Biocorp and connectivity in the drug delivery industry.
YPSOMATE ON – GO FOR SIMPLY CONNECTED
CONNECTIVITY
Philippe Müller
Ypsomed
YPSOMATE ON – GO FOR SIMPLY CONNECTED
Philippe Müller and Silas Mächler discuss the benefits of integrated digital therapy management systems and the role of YpsoMate On –  the newest addition to Ypsomed’s connected device portfolio, and the world’s first prefilled autoinjector with integrated connectivity that automatically logs injections on the user’s therapy management app.
TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS
CONNECTIVITY
Rebecca Beck
BD (Becton Dickinson & Company)
TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS
Rebecca Beck and Hervé Monchoix discuss how stakeholder needs are driving the development of a new, connected injection device from BD, to support decentralised and hybrid clinical trials.
ROUNDTABLE: ALLIANCE TO ZERO
ROUNDTABLE
Sebastian Gerner
Alliance to Zero
ROUNDTABLE: ALLIANCE TO ZERO
Sebastian Gerner, Robert O’Beirn and Sabrina Gérard talk with ONdrugDelivery about the Alliance to Zero, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.
STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY
SUSTAINABILITY
Peter Soelkner
Vetter Pharma
STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY
Peter Soelkner and Thomas Otto discuss how the pharmaceutical service provider focuses on sustainability.
SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT
SUSTAINABILITY
Emil Fraenkel
Phillips Medisize
SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT
Emil Fraenkel and Bjarne Sørensen consider the sustainability of re-usable and disposable autoinjectors, its implications in adding connectivity to drug delivery devices and how it has been an important consideration for Phillips-Medisize in the development of the Aria re-usable autoinjector. 
DATA-DRIVEN SUSTAINABILITY IN AUTOINJECTOR DEVELOPMENT
SUSTAINABILITY
Frederick Gertz
SHL Medical
DATA-DRIVEN SUSTAINABILITY IN AUTOINJECTOR DEVELOPMENT
Frederick Gertz and Yves Steffen outline the company’s approach to sustainability, involving leveraging the experience of its data science department to enhance the output of its sustainability department.
FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE
SUSTAINABILITY
Julie Cotterell
Owen Mumford
FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE
Julie Cotterell discusses the major factors at play driving the direction of innovation in the subcutaneous drug delivery space, with a particular emphasis on the push towards patient self-administration.
EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY
EXPERT VIEW
Kay Sinclair
EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY
Kay Sinclair, Brennan Miles and Charlie Dean provide an overview of eight terms key to a common understanding in the ongoing, and crucial, discussion surrounding sustainability.
CREATING TIMELESS DEVICE TECHNOLOGIES
INJECTION
Andrew Moore
SHL Medical
CREATING TIMELESS DEVICE TECHNOLOGIES
Andrew Moore and Gene Rhode Fuensalida Pantig discuss the importance of a sound strategy for product lifecycle management.
INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT
INTERVIEW
Mathias Romacker
INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT
In this exclusive interview, Mathias Romacker discusses a broad range of topics, from his professional expertise and history seeing the parenteral sector evolve first-hand, to his personal experience as a Crohn’s disease patient making use of the very devices he’s seen grow and develop.
RELENTLESS PRECISION DELIVERS VALUE IN NEEDLE-HANDLING AUTOMATION FOR COMBINATION PRODUCTS
INDUSTRIALISATION
William Jaworski
Mikron Automation
RELENTLESS PRECISION DELIVERS VALUE IN NEEDLE-HANDLING AUTOMATION FOR COMBINATION PRODUCTS
William Jaworski and Michael Gunner discuss the precision and complex manipulation of needles required for the latest combination medical products.
FULLY AUTOMATED ASSEMBLY AND FUNCTIONAL TESTING FOR PEN INJECTORS AND AUTOINJECTORS
INJECTION
Dr Carsten Köhler
BBS Automation
FULLY AUTOMATED ASSEMBLY AND FUNCTIONAL TESTING FOR PEN INJECTORS AND AUTOINJECTORS
Carsten Köhler, Umit Ismail Tsavous and Gerd Vosshage explain the company’s processes for the automated assembly and testing of pen and autoinjectors.
CHALLENGES IN HIGH-VISCOSITY, HIGH-VOLUME DRUG DELIVERY
INJECTION
Michael Roe
KALEO
CHALLENGES IN HIGH-VISCOSITY, HIGH-VOLUME DRUG DELIVERY
Michael Roe discusses the development of the Aerio™ Platform of gas-powered injection systems.
THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER
INJECTION
Jennifer Quint
Pfizer CentreOne
THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER
Jennifer Quint offers insights into how to plan and execute technology transfer effectively, explaining Pfizer CentreOne’s three-phased approach that can successfully support this pivotal event in a drug product programme’s journey to commercialisation.
PRODUCT SHOWCASE: ZwickRoell – Comprehensive Automated Testing Solutions
INDUSTRIALISATION
Wolfgang Moersch
ZwickRoell
PRODUCT SHOWCASE: ZwickRoell – Comprehensive Automated Testing Solutions
ZwickRoell showcases its comprehensive automated testing solutions.
UNDERSTANDING YOUR PROCESS RELIABILITY: COMPLIANCE CONSIDERATIONS FOR EMERGENCY-USE DELIVERY SYSTEMS
INJECTION
Richard Motruk
Kymanox
UNDERSTANDING YOUR PROCESS RELIABILITY: COMPLIANCE CONSIDERATIONS FOR EMERGENCY-USE DELIVERY SYSTEMS
Richard Motruk and Nathan Blazei discuss the issues to be considered in light of the US FDA’s tightened reliability standards for emergency-use autoinjectors.
KEY CONSIDERATIONS FOR AN OPTIMAL EMERGENCY-USE AUTOINJECTOR
INJECTION
Dr Adam Stops
Stevanato Group
KEY CONSIDERATIONS FOR AN OPTIMAL EMERGENCY-USE AUTOINJECTOR
Adam Stops and William Fortina introduce Maverick, an emergency-use autoinjector, and discuss key considerations during the device design and development, for primary packaging and manufacturing and assembly.
HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS
INJECTION
Dr Kate Hudson-Farmer
Phillips Medisize
HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS
Kate Hudson-Farmer discusses how a new electronic reusable autoinjector – the Aria Smart Autoinjector from Phillips-Medisize – has been designed and user-tested to challenge the preconceived ease-of-use notions about electronic autoinjectors, in addition to addressing how macro trends and personal consumer subtleties could become increasingly important in creating a competitive position as devices seek to improve patient engagement.
GX INNOSAFE – GREATER PROTECTION AGAINST NEEDLESTICK INJURIES
PREFILLED SYRINGES
Dr Wenzel Novak
Gerresheimer
GX INNOSAFE – GREATER PROTECTION AGAINST NEEDLESTICK INJURIES
Wenzel Novak and Stefan Verheyden introduce Gx InnoSafe, a novel integrated passive needle safety system for preventing needlestick injuries and accidental reuse of syringes that minimises additional burden on healthcare workers during injection and can be integrated into existing pharmaceutical filling operations without the need for adaptation or conversion of processing lines.
A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT
INJECTION
Asmita Khanolkar
SMC Ltd
A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT
Asmita Khanolkar outlines the latest trends in combination product development to overcome some of the current challenges of high dose/viscosity/volume delivery.
AIDAPTUS<sup>®</sup>: OWEN MUMFORD INTRODUCES ITS NEXT-GENERATION PLATFORM AUTOINJECTOR
INJECTION
Michael Earl
Owen Mumford
AIDAPTUS®: OWEN MUMFORD INTRODUCES ITS NEXT-GENERATION PLATFORM AUTOINJECTOR
Michael Earl introduces the next-generation Aidaptus® autoinjector, explaining how this latest platform device from Owen Mumford can contribute to a faster speed-to-market, increased flexibility during drug development and improved patient outcomes.
INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI
INTERVIEW
Stephen Perry
Kymanox
INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI
Stephen Perry and Nicholas Ciccarelli discuss the August 2021 acquisition of Neuma by Kymanox, highlighting how the acquisition has positioned Kymanox to lead the development of particularly complex drug delivery systems and cutting-edge medical device technologies, providing additional services to progress combination products to market.
PHOTOSTABILITY TESTS OF ANTIBODY DRUGS
PREFILLED SYRINGES
Yoshiko Sakuma
Mitsubishi Gas Chemical
PHOTOSTABILITY TESTS OF ANTIBODY DRUGS
Yoshiko Sakuma and Tomohiro Suzuki provide an overview of Mitsubishi Gas Chemical's OXYCAPT multilayer vial and syringe, with a particular focus on the recent investigations into the interaction of OXYCAPT’s UV barrier with the photostability of antibody drugs, compared with standard cyclo-olefin polymer and Type 1 glass.
Top